 |
인쇄하기
취소
|
Kyowa Hakko Kirin Korea Co. released 'Neulasta’ for the treatment of febrile neutropenia
(Yakup Shinmoon)
Kyowa Hakko Kirin Korea Co. received insurance drug price of 'Neulasta prefilled syringe inj.(nonproprietary name: pegfilgrastim)' which suppresses the expression of 'febrile neutropenia' in patients with cytotoxic chemotherapy for malignant tumor in 2013 Nov, and entered into sales.
'Neulasta' already has been approved by the U.S. FDA in 2002 (3 trillion U.S. sales), an...
Kyowa Hakko Kirin Korea Co. received insurance drug price of 'Neulasta prefilled syringe inj.(nonproprietary name: pegfilgrastim)' which suppresses the expression of 'febrile neutropenia' in patients with cytotoxic chemotherapy for malignant tumor in 2013 Nov, and entered into sales.
'Neulasta' already has been approved by the U.S. FDA in 2002 (3 trillion U.S. sales), an...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.